ABBV - AbbVie Inc logo

ABBV

AbbVie Inc

AbbVie Inc. develops, manufactures, and sells a range of biopharmaceuticals, focusing on autoimmune diseases, blood cancers, migraine treatments, and dermatological products. Its portfolio includes Skyrizi, Rinvoq, Botox, and various eye care medications.

⚕️ Healthcare NYSE Listed 2013 $ USD
$1,000 invested 10 years ago $5,582today

Score Overview

1 Year
Score
Net Growth49.55%
Net TrendGrew
Net Income Consistency
Rev Growth5.27%
Rev TrendGrew
Revenue Consistency
5 Years
Score5.0
Net Growth-45.24%
Net Trend40%
Net Income Consistency
Rev Growth14.57%
Rev Trend80%
Revenue Consistency
10 Years
Score
Net Growth6.16%
Net Trend50%
Net Income Consistency
Rev Growth151.14%
Rev Trend90%
Revenue Consistency
All Time
Score
Net Growth53.10%
Net Trend54%
Net Income Consistency
Rev Growth242.66%
Rev Trend92%
Revenue Consistency

See the full market ranking →

AbbVie Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 45.80B to $ 61.16B and net income declined from $ 4.61B to $ 4.22B. Revenue increased in 4 of those 5 years; net income in 2.

Between 2015 and 2025, revenue grew from $ 22.85B to $ 61.16B and net income declined from $ 5.14B to $ 4.22B. Revenue increased in 9 of those 10 years; net income in 5.

AbbVie Inc currently holds a 5-year HDB Score of 5.0 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 248.76
1 Year2025-08-12
$ 192.6629.12%
5 Years2021-08-12
$ 96.25158.46%
10 Years2016-08-12
$ 44.57458.15%
All Time2013-01-02
$ 20.4112x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 64.38B$ 6.32B
2025$ 61.16B$ 4.22B$ 5.25B
2024$ 56.33B$ 4.27B$ 5.55B
2023$ 54.31B$ 4.86B$ 12.81B
2022$ 58.05B$ 11.83B$ 9.22B
2021$ 56.19B$ 11.54B$ 9.83B
2020$ 45.80B$ 4.61B$ 8.47B
2019$ 33.26B$ 7.88B$ 39.92B
2018$ 32.75B$ 5.68B$ 8.06B
2017$ 28.21B$ 5.30B$ 9.78B
2016$ 25.63B$ 5.95B$ 6.42B
2015$ 22.85B$ 5.14B$ 8.40B
2014$ 19.96B$ 1.77B$ 8.37B
IPO2013$ 18.79B$ 4.12B$ 9.89B

Explore beyond ABBV

You're looking at AbbVie Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies